Get started
Author

Keisuke Amano

An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis
2015 · Akiko Hisamochi, Masayoshi Kage, et al. · Journal of Gastroenterology · 38
PDF
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
2025 · Toru Nakamura, Atsutaka Masuda, et al. · Cells · 33
The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
2023 · Tsubasa Tsutsumi, Dan Nakano, et al. · Nutrients · 25
PDF
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
2024 · Haruki Uojima, Kazumi Yamasaki, et al. · Journal of Gastroenterology · 24
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study
2023 · Tomoya Sano, Keisuke Amano, et al. · Hepatology Research · 24
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
2024 · Hiroyuki Suzuki, Tsubasa Tsutsumi, et al. · Clinical and Molecular Hepatology · 21
PDF
Hepatocellular Carcinoma Surveillance and Survival in a Contemporary Asia-Pacific Cohort
2025 · Ryan Yanzhe Lim, Benjamin Koh, et al. · JAMA Network Open · 17
PDF
Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis
2022 · Teruko Arinaga-Hino, Tatsuya Ide, et al. · Scientific Reports · 17
PDF
Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after hepatitis C virus eradication
2021 · Toshihiro Kawaguchi, Tatsuya Ide, et al. · Molecular and Clinical Oncology · 16
PDF
Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C
2020 · Jun Itakura, Masayuki Kurosaki, et al. · JHEP Reports · 16
Risk of malignancies in autoimmune hepatitis type 1 patients with a long‐term follow‐up in Japan
2017 · Teruko Arinaga‐Hino, Tatsuya Ide, et al. · Hepatology Research · 16
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease
2023 · Haruki Uojima, Kadzuki Nakabayashi, et al. · Journal of Gastroenterology · 15
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis
2022 · Tomoya Sano, Keisuke Amano, et al. · Hepatology Research · 15
Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1
2022 · Hiroyuki Suzuki, Teruko Arinaga-Hino, et al. · Frontiers in Medicine · 12
PDF
Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C
2017 · Toshihiro Kawaguchi, Tatsuya Ide, et al. · Clinical Journal of Gastroenterology · 12
Hepatitis B virus‐related hepatocellular carcinoma in young adults: Efficacy of nationwide selective vaccination
2019 · Hiroshi Yotsuyanagi, Tomoko Takano, et al. · Hepatology Research · 9
Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012
2014 · KEISUKE AMANO, TAKUMI KAWAGUCHI, et al. · Molecular and Clinical Oncology · 9
PDF
Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1
2016 · Tatsuya Ide, Yuichiro Eguchi, et al. · PLoS ONE · 8
PDF
Clinical trial: extended treatment duration of peginterferon‐alpha2b plus ribavirin for 72 and 96 weeks in hepatitis C genotype 1‐infected late responders
2009 · M. NAGAKI, M. SHIMIZU, et al. · Alimentary Pharmacology & Therapeutics · 8
PDF
Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
2021 · Tomoya Sano, Takumi Kawaguchi, et al. · Life · 7
PDF
Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter‐3 in immunoglobulin G4‐related autoimmune hepatitis
2018 · Toshihiro Araki, Teruko Arinaga‐Hino, et al. · Hepatology Research · 7
Prednisolone-responsive primary sclerosing cholangitis with autoimmune hemolytic anemia: a case report and review of the literature
2020 · Toshihiro Kawaguchi, Teruko Arinaga-Hino, et al. · Clinical Journal of Gastroenterology · 6
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
2024 · Toru Nakamura, Masahito Nakano, et al. · Clinical and Molecular Hepatology · 5
An ever-increasing metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: what are problems and countermeasures?
2023 · Shigeo Shimose, Tsubasa Tsutsumi, et al. · HepatoBiliary Surgery and Nutrition · 5
PDF
The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study
2025 · Keisuke Amano, Tomoya Sano, et al. · Internal Medicine · 4
PDF
Works count: 50
Citation count: 396
H-index: 13
I10-index: 15
Year
Topic
Type